MX2017016930A - Method of treatment of diabetic foot ulcers. - Google Patents
Method of treatment of diabetic foot ulcers.Info
- Publication number
- MX2017016930A MX2017016930A MX2017016930A MX2017016930A MX2017016930A MX 2017016930 A MX2017016930 A MX 2017016930A MX 2017016930 A MX2017016930 A MX 2017016930A MX 2017016930 A MX2017016930 A MX 2017016930A MX 2017016930 A MX2017016930 A MX 2017016930A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- diabetic foot
- foot ulcers
- ulcers
- diabetic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
A novel method of treating, preventing and maintaining diabetic foot ulcers is described.
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2017016930A MX2017016930A (en) | 2017-12-19 | 2017-12-19 | Method of treatment of diabetic foot ulcers. |
US16/126,605 US20190183894A1 (en) | 2017-12-19 | 2018-09-10 | Method of treatment of diabetic foot ulcers |
JP2020554381A JP2021506983A (en) | 2017-12-19 | 2018-10-02 | How to treat diabetic foot ulcer |
AU2018388621A AU2018388621A1 (en) | 2017-12-19 | 2018-10-02 | Method of treatment of diabetic foot ulcers |
BR112020012384-6A BR112020012384A2 (en) | 2017-12-19 | 2018-10-02 | diabetic foot ulcers treatment method |
PCT/US2018/053840 WO2019125577A1 (en) | 2017-12-19 | 2018-10-02 | Method of treatment of diabetic foot ulcers |
EP18891320.6A EP3727366A4 (en) | 2017-12-19 | 2018-10-02 | Method of treatment of diabetic foot ulcers |
CN201880082717.1A CN111491630A (en) | 2017-12-19 | 2018-10-02 | Method for treating diabetic foot ulcers |
CA3085994A CA3085994A1 (en) | 2017-12-19 | 2018-10-02 | Method of treatment of diabetic foot ulcers |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2017016930A MX2017016930A (en) | 2017-12-19 | 2017-12-19 | Method of treatment of diabetic foot ulcers. |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017016930A true MX2017016930A (en) | 2019-06-20 |
Family
ID=66815450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017016930A MX2017016930A (en) | 2017-12-19 | 2017-12-19 | Method of treatment of diabetic foot ulcers. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20190183894A1 (en) |
EP (1) | EP3727366A4 (en) |
JP (1) | JP2021506983A (en) |
CN (1) | CN111491630A (en) |
AU (1) | AU2018388621A1 (en) |
BR (1) | BR112020012384A2 (en) |
CA (1) | CA3085994A1 (en) |
MX (1) | MX2017016930A (en) |
WO (1) | WO2019125577A1 (en) |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL139073A0 (en) * | 1999-10-21 | 2001-11-25 | Pfizer | Treatment of neuropathy |
GB0000561D0 (en) * | 2000-01-11 | 2000-03-01 | Pfizer Ltd | Treatment of diabetic ulcers |
US20030105108A1 (en) * | 2002-12-19 | 2003-06-05 | Wood Ralph E. | Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
IL153426A0 (en) * | 2000-06-30 | 2003-07-06 | Pfizer | Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
JP2004506009A (en) * | 2000-08-11 | 2004-02-26 | ファイザー・インク | Treatment of insulin resistance syndrome |
SV2002000624A (en) * | 2001-09-05 | 2002-09-12 | Palacio John L | SILDENAFIL MALEATE |
GB0202254D0 (en) * | 2002-01-31 | 2002-03-20 | Pfizer Ltd | Prevention of scarring |
JP2006520777A (en) * | 2003-03-17 | 2006-09-14 | ファイザー・プロダクツ・インク | Treatment of type 1 diabetes with PDE5 inhibitors |
US20040186046A1 (en) * | 2003-03-17 | 2004-09-23 | Pfizer Inc | Treatment of type 1 diabetes with PDE5 inhibitors |
EP1676573A1 (en) * | 2004-12-30 | 2006-07-05 | Laboratorios Del Dr. Esteve, S.A. | Phamaceutical composition comprising a 2,5-dihydroxybenzenesulfonic-compound, a potassium ion channel modulator and a phosphodiesterase type 5 inhibitor |
WO2011075655A1 (en) * | 2009-12-18 | 2011-06-23 | Exodos Life Sciences Limited Partnership | Methods and compositions for treating peripheral vascular disease |
CN105353095B (en) * | 2015-11-16 | 2017-10-20 | 华南农业大学 | A kind of immunologic detection method of silaenafil and its analogue |
-
2017
- 2017-12-19 MX MX2017016930A patent/MX2017016930A/en unknown
-
2018
- 2018-09-10 US US16/126,605 patent/US20190183894A1/en not_active Abandoned
- 2018-10-02 CN CN201880082717.1A patent/CN111491630A/en active Pending
- 2018-10-02 JP JP2020554381A patent/JP2021506983A/en active Pending
- 2018-10-02 CA CA3085994A patent/CA3085994A1/en active Pending
- 2018-10-02 BR BR112020012384-6A patent/BR112020012384A2/en not_active Application Discontinuation
- 2018-10-02 EP EP18891320.6A patent/EP3727366A4/en not_active Withdrawn
- 2018-10-02 AU AU2018388621A patent/AU2018388621A1/en not_active Abandoned
- 2018-10-02 WO PCT/US2018/053840 patent/WO2019125577A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3727366A1 (en) | 2020-10-28 |
US20190183894A1 (en) | 2019-06-20 |
BR112020012384A2 (en) | 2021-02-23 |
WO2019125577A1 (en) | 2019-06-27 |
CN111491630A (en) | 2020-08-04 |
AU2018388621A1 (en) | 2020-07-02 |
EP3727366A4 (en) | 2021-04-21 |
JP2021506983A (en) | 2021-02-22 |
CA3085994A1 (en) | 2019-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2572642B (en) | Treatment of diabetic foot ulcers | |
NZ755166A (en) | Biofilm disrupting composition for use on chronic wounds | |
AU2017382297A8 (en) | Phosphodiesterase inhibitors and methods of microbial treatment | |
MX2023001527A (en) | Compounds with ferroptosis inducing activity and methods of their use. | |
MX2020005567A (en) | Methods of treatment with asparaginase. | |
MX2017010150A (en) | Recombinant probiotic bacteria. | |
MY190411A (en) | Improved uricase sequences and methods of treatment | |
MX2018004840A (en) | Wound dressing. | |
WO2019102380A8 (en) | Therapeutic treatment of breast cancer based on c-maf status | |
MX2017011279A (en) | Method of treatment with tradipitant. | |
WO2019040106A3 (en) | Compounds, salts thereof and their use in the treatment of diseases | |
MX2020009939A (en) | Methods of treating prader-willi syndrome. | |
MX2021000847A (en) | Methods of treating cancer with pi3k inhibitor, gdc-0077. | |
AU2018337076A1 (en) | Method of treatment | |
MY192385A (en) | Methods of treating acute kidney injury | |
MX2017016114A (en) | Methods of treating or preventing a proteopathy. | |
MX2017009246A (en) | Combination drug. | |
GEP20186939B (en) | Medical treatments based on anamorelin | |
TW201613639A (en) | Methods for treating cardiovascular diseases | |
SE1500342A1 (en) | New bandage | |
MX2017016930A (en) | Method of treatment of diabetic foot ulcers. | |
EA201992210A1 (en) | PREVENTION AND / OR TREATMENT OF INFLAMMATORY DISEASES OF THE SKIN | |
WO2018058144A8 (en) | Ship1 activator for treating prostatitis | |
GB2558090A (en) | Combination of zinc pyrithione and silver sulfadiazine for the prevention and treatment of microbial infections | |
TW202417015A (en) | Treatment of hemophilia with fitusiran |